Benjamin R. Cowen
Direktor/Vorstandsmitglied bei INCON CO.,LTD.
Aktive Positionen von Benjamin R. Cowen
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| INCON CO.,LTD. | Direktor/Vorstandsmitglied | - | - |
Atrin Pharmaceuticals LLC
 Atrin Pharmaceuticals LLC BiotechnologyHealth Technology Atrin Pharmaceuticals LLC engages in discovery and development of proprietary medications. It offers ATRN-502, a p53 activator; and ATRN-507, a dual ligand showing specificity and selectivity against cancer cells. The firm also provides Atrize, a platform that offers phenotypic FACS-based screening that is applicable across R&D, clinical applications, and a tool for personalized medicine. The company was founded by Oren Gilad and Kevin D. Smith in 2011 and is headquartered in Doylestown, PA. | Direktor/Vorstandsmitglied | 01.01.2012 | - |
ImmunoMet Therapeutics, Inc.
 ImmunoMet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImmunoMet Therapeutics, Inc. operates as a development-stage biopharmaceutical company that develops and commercializes novel oncology products. It offers novel technology that designed to disrupt cancer cell growth and enhance anti-cancer immunity. The company was founded in July 2015 and is headquartered in Houston, TX. | Vorstandsvorsitzender | 01.11.2017 | - |
| Präsident | - | - | |
| Geschäftsführer | 01.01.2016 | 01.01.2017 |
Karriereverlauf von Benjamin R. Cowen
Ehemalige bekannte Positionen von Benjamin R. Cowen
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MILESTONE PHARMACEUTICALS INC. | Corporate Officer/Principal | - | - |
Ausbildung von Benjamin R. Cowen
| University of Illinois | Doctorate Degree |
| Carnegie Mellon University | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 5 |
| Kanada | 2 |
| Südkorea | 2 |
Operativ
| Director/Board Member | 2 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Consumer Durables | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| MILESTONE PHARMACEUTICALS INC. | Health Technology |
| INCON CO.,LTD. | Consumer Durables |
| Private Unternehmen | 2 |
|---|---|
Atrin Pharmaceuticals LLC
Atrin Pharmaceuticals LLC BiotechnologyHealth Technology Atrin Pharmaceuticals LLC engages in discovery and development of proprietary medications. It offers ATRN-502, a p53 activator; and ATRN-507, a dual ligand showing specificity and selectivity against cancer cells. The firm also provides Atrize, a platform that offers phenotypic FACS-based screening that is applicable across R&D, clinical applications, and a tool for personalized medicine. The company was founded by Oren Gilad and Kevin D. Smith in 2011 and is headquartered in Doylestown, PA. | Health Technology |
ImmunoMet Therapeutics, Inc.
ImmunoMet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImmunoMet Therapeutics, Inc. operates as a development-stage biopharmaceutical company that develops and commercializes novel oncology products. It offers novel technology that designed to disrupt cancer cell growth and enhance anti-cancer immunity. The company was founded in July 2015 and is headquartered in Houston, TX. | Health Technology |
- Börse
- Insiders
- Benjamin R. Cowen
- Erfahrung
